Can a 3-Session stress course ease the burden on caregivers of ice users?
NCT ID NCT07714642
First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time
Summary
This study tests whether a short, group-based stress management training program can help caregivers of people with methamphetamine ("ice") addiction and psychosis. Caregivers often face high levels of emotional and physical stress, which can lead to burnout. The program teaches relaxation, coping strategies, and cognitive reframing over three weekly sessions. Researchers will measure changes in caregiver burden, perceived stress, expressed emotions, and general mental health using standard questionnaires.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- a 3-session group-based stress management training program (O'Connor's 2003 model) covering relaxation, coping strategies, cognitive reframing, and guided imagery
- What this could lead to
- If effective, this program could offer a simple, low-cost way to reduce stress and burnout among caregivers of people with severe substance use disorders.
- What could go wrong
- This is a small, early-stage trial with only 30 participants, so results may not apply broadly. The program is short (3 sessions) and may not produce lasting changes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
30 people
The number who actually took part.
- Started
-
Mar 2026
- Expected to finish
-
Aug 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria Caregivers of patients aged 18 to 65 years. Must have been actively providing care to the patient for at least the last three months. Must possess the ability to understand and respond to the study questionnaires. Agree to take part in the study and provide informed consent. Must be directly responsible for the daily care of the patient. \- Exclusion Criteria: Giving care to the patient for less than three months. Caregivers of patients who live entirely alone (since direct caregiving interactions are required). Caregivers who decline or refuse to participate in the study.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Caregiver burden in methamphetamine use disorder are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Government college university Faislabad
Faisalabad, Punjab Province, 38000, Pakistan